News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Will Pharma's Future Be Based On The Carl Icahn Business Model?



3/5/2014 6:22:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

For today, the buzz surrounding Carl Icahn derives from his initiative to separate PayPal from eBay (EBAY). More frequently, people tend to equate Icahn with his investment strategy; including his activism in Apple AAPL +0.62% and significant profits in Netflix NFLX +2.17% ownership. But an Icahn initiative that is drawing less attention and may have far greater social impact is his activism in the upcoming merger of Actavis ACT +3.34% and Forest Laboratories (FRX).

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes


comments powered by Disqus
Forbes
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES